Acute ST-segment elevation myocardial infarction after amoxycillin-induced anaphylactic shock in a young adult with normal coronary arteries: a case report.
BACKGROUND
Acute myocardial infarction (MI) following anaphylaxis is rare, especially in subjects with normal coronary arteries. The exact pathogenetic mechanism of MI in anaphylaxis remains unclear.


METHODS
The case of a 32-year-old asthmatic male with systemic anaphylaxis, due to oral intake of 500 mg amoxycillin, complicated by acute ST-elevation MI is the subject of this report. Following admission to the local Health Center and almost simultaneously with the second dose of subcutaneous epinephrine (0.2 mg), the patient developed acute myocardial injury. Coronary arteriography, performed before discharge, showed no evidence of obstructive coronary artery disease. In vivo allergological evaluation disclosed strong sensitivity to amoxycillin and the minor (allergenic) determinants of penicillin.


CONCLUSIONS
Acute ST-elevation MI is a rare but potential complication of anaphylactic reactions, even in young adults with normal coronary arteries. Coronary artery spasm appears to be the main causative mechanism of MI in the setting of "cardiac anaphylaxis". However, on top of the vasoactive reaction, a thrombotic occlusion, induced by mast cell-derived mediators and facilitated by prolonged hypotension, cannot be excluded as a possible contributory factor.
Gikas
Aristofanis
A
Health Center of Salamis, Salamis, Greece. argikas@internet.gr
Lazaros
George
G
Kontou-Fili
Kalliopi
K
D000328:Adult; D000658:Amoxicillin / Q000009:adverse effects*; D000707:Anaphylaxis / Q000139:chemically induced / Q000150:complications*; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D017023:Coronary Angiography; D003331:Coronary Vessels / Q000502:physiology; D004342:Drug Hypersensitivity / Q000150:complications; D004562:Electrocardiography; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000209:etiology*
D000900:Anti-Bacterial Agents; D000658:Amoxicillin
Am Heart J. 1986 Jun;111(6):1193-5
2940853
J Am Coll Cardiol. 1987 Dec;10(6):1207-13
3680788
Allergy. 1992 Oct;47(5):576-8
1485665
Ann Cardiol Angeiol (Paris). 1992 Oct;41(8):433-5
1363684
Ann Allergy. 1993 May;70(5):396-8
8498731
Am Heart J. 1994 Oct;128(4):820-3
7942454
J Immunol. 1995 Mar 15;154(6):2855-65
7533185
Circulation. 1995 Sep 1;92(5):1084-8
7648650
Ann Allergy Asthma Immunol. 1996 Aug;77(2):101-4
8760774
Clin Cardiol. 1997 Jul;20(7):656-8
9220183
Ann Cardiol Angeiol (Paris). 1997 May-Jun;46(5-6):311-5
9295891
Int J Clin Lab Res. 1997;27(3):178-84
9352380
Tex Heart Inst J. 1998;25(3):194-7
9782559
Circulation. 1999 Jan 26;99(3):361-9
9918522
Rev Esp Cardiol. 1999 Aug;52(8):622-4
10439663
Rev Esp Cardiol. 2000 Dec;53(12):1663-6
11171492
Clin Cardiol. 2001 Mar;24(3):258-9
11288975
J Clin Anesth. 2001 Dec;13(8):582-4
11755328
Eur Ann Allergy Clin Immunol. 2003 Feb;35(2):61-3
12674041
Mayo Clin Proc. 2003 Dec;78(12):1557-60
14661686
Allergy. 2004 Apr;59(4):466-7
15005775
Novartis Found Symp. 2004;257:133-49; discussion 149-60, 276-85
15025396
J Investig Allergol Clin Immunol. 2004;14(2):162-4
15301308
Am J Cardiol. 2004 Oct 1;94(7):859-63
15464665
Am Heart J. 1981 Nov;102(5):819-22
6795908
N Engl J Med. 1983 Jul 28;309(4):220-3
6866037